UK markets closed

Ultimovacs ASA (ULTI.OL)

Oslo - Oslo Delayed price. Currency in NOK
Add to watchlist
7.06+0.45 (+6.81%)
At close: 04:28PM CEST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-189,239
-189,239
-167,792
-164,722
-120,552
Depreciation & amortisation
2,768
2,768
2,648
2,703
2,720
Stock-based compensation
14,256
14,256
20,395
11,595
6,777
Change in working capital
8,885
8,885
-6,988
23,860
6,395
Other working capital
-189,852
-189,852
-167,890
-125,913
-113,505
Other non-cash items
-13,747
-13,747
-8,782
-2,883
-4,309
Net cash provided by operating activities
-189,827
-189,827
-167,695
-125,828
-108,223
Cash flows from investing activities
Investments in property, plant and equipment
-25
-25
-195
-85
-5,282
Other investing activities
-
-
-1
-
1
Net cash used for investing activities
14,034
14,034
8,691
2,977
-736
Net change in cash
-177,640
-177,640
-155,426
137,106
42,058
Cash at beginning of period
425,309
425,309
574,168
440,925
399,607
Cash at end of period
266,559
266,559
425,309
574,168
440,925
Free cash flow
Operating cash flow
-189,827
-189,827
-167,695
-125,828
-108,223
Capital expenditure
-25
-25
-195
-85
-5,282
Free cash flow
-189,852
-189,852
-167,890
-125,913
-113,505